Thromboembolic events occur in primary membranous nephropathy, especially when serum albumin is less than 2.8?g/dl. In such patients, a conundrum arises concerning anticipated benefits and risks when a prophylactic oral anticoagulant is considered. Lee et al. describe a flexible Markov decision tree program to aid decision making. Its application to individual patients will probably be useful, but physicians will need to assess patients tolerance for the benefit-to-risk ratio, considering the many factors bearing on the risk of thromboembolic events and/or serious bleeding.
Author: Richard J Glassock
Reference: Kidney Int 85: 1265-1266; doi:10.1038/ki.2013.541
Additional Info
-
Language:
English -
Contains Audio:
No -
Content Type:
Articles -
Source:
KI -
Year:
2013 -
Members Only:
No